BlackRock Investment Management’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
$134M Sell
6,192,388
-665,390
-10% -$14.5M 0.16% 135
2016
Q3
$163M Sell
6,857,778
-308,139
-4% -$7.35M 0.2% 106
2016
Q2
$167M Buy
7,165,917
+3,552,349
+98% +$76.9M 0.21% 102
2016
Q1
$68M Sell
3,613,568
-46,409
-1% -$815K 0.09% 219
2015
Q4
$67.5M Buy
3,659,977
+126,081
+4% +$2.26M 0.09% 217
2015
Q3
$58M Buy
3,533,896
+75,696
+2% +$1.29M 0.08% 239
2015
Q2
$61.2M Buy
3,458,200
+357,586
+12% +$6.39M 0.08% 242
2015
Q1
$55M Buy
3,100,614
+177,303
+6% +$2.8M 0.07% 270
2014
Q4
$38.7M Buy
2,923,311
+90,077
+3% +$1.15M 0.05% 340
2014
Q3
$33.5M Sell
2,833,234
-21,804
-0.8% -$275K 0.05% 357
2014
Q2
$36.5M Buy
2,855,038
+338,883
+13% +$4.41M 0.05% 350
2014
Q1
$34M Sell
2,516,155
-89,774
-3% -$1.18M 0.05% 343
2013
Q4
$31.3M Buy
2,605,929
+46,059
+2% +$544K 0.05% 349
2013
Q3
$30.1M Buy
2,559,870
+75,774
+3% +$820K 0.05% 342
2013
Q2
$23M Buy
+2,484,096
New +$21.1M 0.04% 384

Other funds holding BSX

BlackRock Investment Management's BSX Position: Q4 2016 in Review

BlackRock Investment Management reduced its Boston Scientific (BSX) stake by 9.7% in Q4 2016, selling an estimated $14.5M and leaving 6,192,388 shares worth $134M. The position accounts for 0.16% of the portfolio, ranked #135.

BlackRock Investment Management first reported a position in BSX in Q2 2013 and has held it in 15 quarters since. The position peaked at $167M in Q2 2016. 556 funds tracked by Wall St. Rank hold BSX as of Q4 2016.

  • BlackRock Investment Management held 6,192,388 shares of Boston Scientific worth $134M as of Q4 2016.
  • BlackRock Investment Management sold 665,390 Boston Scientific shares in Q4 2016, an estimated $14.5M.
  • Boston Scientific made up 0.16% of BlackRock Investment Management's portfolio in Q4 2016, its #135 holding.
  • BlackRock Investment Management first reported a position in Boston Scientific in Q2 2013 and has held it in 15 quarters since.
  • BlackRock Investment Management's Boston Scientific position peaked at $167M in Q2 2016.
  • 556 funds tracked by Wall St. Rank held Boston Scientific as of Q4 2016.

Based on BlackRock Investment Management's 13F filing for Q4 2016, filed 10 Feb 2017.